The EMQN responds to innovative testing technologies with appropriate new EQA schemes to drive quality and accelerate adoption.
EMQN closely tracks developments in diagnostic testing as new technologies are adopted and applied. EMQN responds to these developments with new EQA schemes, providing support to progressive laboratories. Participating laboratories benefit from an independent measure of quality early in the adoption process.
An example of EMQN leadership is in the development of DNA sequencing schemes.
Other schemes currently being piloted, or under consideration include the development of EQA methodologies for: